Kroger Co vs Teladoc Health Inc — how do they compare? Kroger Co trades at $61.64 (market cap $36.27B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Kroger Co is far larger — about 35.9× Teladoc Health Inc's market cap, and Kroger Co pays a 2.54% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kroger Co for 108 Days and Teladoc Health Inc for 39 Days on average.
| KR | TDOC | |
|---|---|---|
Market Cap | $36.27B | $1.01B |
Volume | 8,301,523 | 4,668,477 |
Sector | Consumer Staples | Health |
52-Week High | $75.60 | $9.72 |
52-Week Low | $55.53 | $4.47 |
Typical Hold Time | 108 Days | 39 Days |
Enterprise Value | $57.69B | $1.27B |
Dividend Yield | 2.54% | — |
Signals from Pluang's Aura AI — not financial advice
Kroger (KR) trades at $61.41, up 3.65% with a bullish technical signal and positive analyst sentiment. The stock shows strong fundamentals with $147.12B revenue, 23.11% gross margins, and consistent dividend payments. Recent earnings beat expectations in Q2 2026, while Q1 2026 slightly missed. Technical indicators show the stock trading near pivot point resistance at $62 with solid support at $59-60 levels. The company maintains robust cash flow generation with $5.79B from operations in 2025.
Kroger presents a compelling investment case with attractive valuation (P/S 0.26), strong analyst support (47.72% buy ratings), and $70.62 consensus price target offering 15% upside. Key risks include integration challenges with Giant Eagle acquisition, cost pressures affecting 2026 margins, and competitive threats from Walmart. The stock's digital growth initiatives and retail media expansion provide growth catalysts, though investors should monitor identical sales performance and acquisition integration progress.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →